Don’t miss a morning Plenary Session on advances in artificial intelligence, an afternoon address by NCI Director Anthony G. Letai, MD, PhD, FAACR, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.

The fourth Plenary Session will integrate population trends, etiologic clues, tumor biology, and real‑world outcomes to discuss potential causes and actionable opportunities for prevention.

On Monday, two cancer research luminaries will discuss strategies for integrating both molecular and digital pathology and work on how neutrophils are reprogrammed on behalf of cancer within the tumor microenvironment.

A Tuesday session will include specially selected presentations from the most recent San Antonio Breast Cancer Symposium (SABCS), an international forum for foundational discoveries in breast cancer that is cosponsored by the AACR.

Don’t miss the Opening Ceremony and Opening Plenary, the first New Drugs on the Horizon sessions, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.

The third Plenary Session will feature speakers who are harnessing the power of artificial intelligence (AI) to augment approaches to complex cancer research.

A three-part series will offer a glimpse at 12 innovative therapeutics that are being publicly disclosed for the very first time and may soon reshape the oncology landscape.

Researchers working to overcome challenges with chimeric antigen receptor (CAR) T-cell therapies will speak during a Special Session jointly organized by the AACR and the American Society of Clinical Oncology (ASCO).

A Special Session jointly organized by the AACR and the Japanese Cancer Association (JCA) will examine some of the crucial questions surrounding the development of lung cancer in never-smokers and why this is such an urgent area for research.

Don’t miss the first two Clinical Trials Minisymposia, the Discovery Science Plenary, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.